Compounds > flucytosine

flucytosine and anidulafungin

flucytosine has been researched along with anidulafungin in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's8 (53.33)29.6817
2010's4 (26.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Dimopoulos, G; Falagas, ME; Velegraki, A1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE1
Andes, DR; Crawford, K; Marchillo, K; Nett, JE1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA1
Denning, DW; Moore, CB; Oakley, KL1
Steinbach, WJ1
Goldstein, BP; Hoban, DJ; Karlowsky, JA; Zhanel, GG1
Caggiano, G; Carone, A; Corbo, F; Franchini, C; Montagna, MT; Muraglia, M; Piarulli, M; Rosato, A; Schiavone, BI1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E1
Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J1
Bicanic, T; Bignell, EM; Brown, AJP; Harrison, TS; Hoenigl, M; John, LLH; Thomson, DD1

Reviews

2 review(s) available for flucytosine and anidulafungin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005

Other Studies

13 other study(ies) available for flucytosine and anidulafungin

ArticleYear
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies

2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain

2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia

2009
Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Glucans; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Polyenes; Pyrimidines

2010
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
    Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:1

    Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test

1998
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:1

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Reproducibility of Results

2001
In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    International journal of antimicrobial agents, 2006, Volume: 27, Issue:2

    Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Interactions; Echinocandins; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Peptides, Cyclic

2006
In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2012, Volume: 8, Issue:4

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Imidazoles

2012
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult

2019
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.
    The Journal of antimicrobial chemotherapy, 2020, 05-01, Volume: 75, Issue:5

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole

2020
Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris
    Antimicrobial agents and chemotherapy, 2023, 06-15, Volume: 67, Issue:6

    Topics: Anidulafungin; Antifungal Agents; Candida; Candida auris; Flucytosine; Microbial Sensitivity Tests

2023